Search research articles
Contact Us
Filters
Showing results (471-480 of 613) with videos related to
Page
of 62
Sort By:
Journal of Clinical Lipidology
|
February 5, 2011
Effects of adding extended-release niacin and colesevelam to statin therapy on lipid levels in subjects with atherosclerotic disease
Andrew Moore, Binh An P Phan, Catherine Challender, et al.
Infectious Diseases (London, England)
|
June 26, 2020
Patients with surgically treated culture-negative native joint septic arthritis have less severe disease and better outcomes
Ziv Paz, Mary Louise Fowler, Clara Zhu, et al.
Child Maltreatment
|
July 25, 2018
Early Exposure to Child Maltreatment and Academic Outcomes
Joseph P Ryan, Brian A Jacob, Max Gross, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 14, 2009
Evidence for endoscopic ulcers as meaningful surrogate endpoint for clinically significant upper gastrointestinal harm
Andrew Moore, Ingvar Bjarnason, Byron Cryer, et al.
Infection
|
May 31, 2017
Clinical characteristics and outcomes of septic bursitis
Sarah B Lieber, Mary Louise Fowler, Clara Zhu, et al.
Arthritis Research & Therapy
|
April 17, 2015
Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis
Anneloes van Walsem, Shaloo Pandhi, Richard M Nixon, et al.
The Cochrane Database of Systematic Reviews
|
January 24, 2019
Pregabalin for neuropathic pain in adults
Sheena Derry, Rae Frances Bell, Sebastian Straube, et al.
The Cochrane Database of Systematic Reviews
|
September 3, 2013
Interventions for the reduction of prescribed opioid use in chronic non-cancer pain
Jude Windmill, Emma Fisher, Christopher Eccleston, et al.
Journal of Medical Economics
|
February 28, 2012
Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine
Robert Ikenberg, Nadine Hertel, R Andrew Moore, et al.
The Cochrane Database of Systematic Reviews
|
October 6, 2015
Oral nonsteroidal anti-inflammatory drugs for neuropathic pain
R Andrew Moore, Ching-Chi Chi, Philip J Wiffen, et al.
Page
of 62
Search research articles
Search
Showing results (471-480 of 613) with videos related to
Sort By:
Page
of 62
Journal of Clinical Lipidology
|
February 5, 2011
Effects of adding extended-release niacin and colesevelam to statin therapy on lipid levels in subjects with atherosclerotic disease
Andrew Moore, Binh An P Phan, Catherine Challender, et al.
Infectious Diseases (London, England)
|
June 26, 2020
Patients with surgically treated culture-negative native joint septic arthritis have less severe disease and better outcomes
Ziv Paz, Mary Louise Fowler, Clara Zhu, et al.
Child Maltreatment
|
July 25, 2018
Early Exposure to Child Maltreatment and Academic Outcomes
Joseph P Ryan, Brian A Jacob, Max Gross, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 14, 2009
Evidence for endoscopic ulcers as meaningful surrogate endpoint for clinically significant upper gastrointestinal harm
Andrew Moore, Ingvar Bjarnason, Byron Cryer, et al.
Infection
|
May 31, 2017
Clinical characteristics and outcomes of septic bursitis
Sarah B Lieber, Mary Louise Fowler, Clara Zhu, et al.
Arthritis Research & Therapy
|
April 17, 2015
Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis
Anneloes van Walsem, Shaloo Pandhi, Richard M Nixon, et al.
The Cochrane Database of Systematic Reviews
|
January 24, 2019
Pregabalin for neuropathic pain in adults
Sheena Derry, Rae Frances Bell, Sebastian Straube, et al.
The Cochrane Database of Systematic Reviews
|
September 3, 2013
Interventions for the reduction of prescribed opioid use in chronic non-cancer pain
Jude Windmill, Emma Fisher, Christopher Eccleston, et al.
Journal of Medical Economics
|
February 28, 2012
Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine
Robert Ikenberg, Nadine Hertel, R Andrew Moore, et al.
The Cochrane Database of Systematic Reviews
|
October 6, 2015
Oral nonsteroidal anti-inflammatory drugs for neuropathic pain
R Andrew Moore, Ching-Chi Chi, Philip J Wiffen, et al.
Page
of 62